Literature DB >> 26354816

Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis.

Caroline Chartrand1, Nicolas Tremblay2, Christian Renaud3, Jesse Papenburg4.   

Abstract

Respiratory syncytial virus (RSV) rapid antigen detection tests (RADT) are extensively used in clinical laboratories. We performed a systematic review and meta-analysis to evaluate the accuracy of RADTs for diagnosis of RSV infection and to determine factors associated with accuracy estimates. We searched EMBASE and PubMed for diagnostic-accuracy studies of commercialized RSV RADTs. Studies reporting sensitivity and specificity data compared to a reference standard (reverse transcriptase PCR [RT-PCR], immunofluorescence, or viral culture) were considered. Two reviewers independently extracted data on study characteristics, diagnostic-accuracy estimates, and study quality. Accuracy estimates were pooled using bivariate random-effects regression models. Heterogeneity was investigated with prespecified subgroup analyses. Seventy-one articles met inclusion criteria. Overall, RSV RADT pooled sensitivity and specificity were 80% (95% confidence interval [CI], 76% to 83%) and 97% (95% CI, 96% to 98%), respectively. Positive- and negative-likelihood ratios were 25.5 (95% CI, 18.3 to 35.5) and 0.21 (95% CI, 0.18 to 0.24), respectively. Sensitivity was higher in children (81% [95% CI, 78%, 84%]) than in adults (29% [95% CI, 11% to 48%]). Because of this disparity, further subgroup analyses were restricted to pediatric data (63 studies). Test sensitivity was poorest using RT-PCR as a reference standard and highest using immunofluorescence (74% versus 88%; P < 0.001). Industry-sponsored studies reported significantly higher sensitivity (87% versus 78%; P = 0.01). Our results suggest that the poor sensitivity of RSV RADTs in adults may preclude their use in this population. Furthermore, industry-sponsored studies and those that did not use RT-PCR as a reference standard likely overestimated test sensitivity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26354816      PMCID: PMC4652120          DOI: 10.1128/JCM.01816-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  103 in total

Review 1.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

2.  Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory tract infection.

Authors:  P M Adcock; G G Stout; M A Hauck; G S Marshall
Journal:  Pediatr Infect Dis J       Date:  1997-09       Impact factor: 2.129

3.  Comparison of the VIDAS RSV assay and the Abbott Testpack RSV with direct immunofluorescence for detection of respiratory syncytial virus in nasopharyngeal aspirates.

Authors:  H Miller; R Milk; F Diaz-Mitoma
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

4.  Evaluation of the 3M rapid detection test for respiratory syncytial virus (RSV) in children during the early stages of the 2009 RSV season.

Authors:  Iona Munjal; Philip Gialanella; Cheryl Goss; John C McKitrick; Jeffrey R Avner; Qiulu Pan; Nathan Litman; Michael H Levi
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections.

Authors:  Kevin Purcell; Jaime Fergie
Journal:  Arch Pediatr Adolesc Med       Date:  2002-04

6.  Evaluation of respiratory syncytial virus detection by rapid antigen tests in childhood.

Authors:  U Schauer; G Ihorst; A Rohwedder; G Petersen; R Berner; H D Frank; J Forster; V Stephan
Journal:  Klin Padiatr       Date:  2006-07-24       Impact factor: 1.349

7.  Evaluation of respiratory syncytial virus (RSV) direct antigen detection assays for use in point-of-care testing.

Authors:  G P Leonardi; A M Wilson; M Dauz; A R Zuretti
Journal:  J Virol Methods       Date:  2014-12-08       Impact factor: 2.014

8.  Test characteristics of the respiratory syncytial virus enzyme-linked immunoabsorbent assay in febrile infants < or = 60 days of age.

Authors:  Peter Dayan; Faiz Ahmad; Jacqueline Urtecho; Michael Novick; Patricia Dixon; Debbie Levine; Steven Miller
Journal:  Clin Pediatr (Phila)       Date:  2002 Jul-Aug       Impact factor: 1.168

9.  Evaluation of a rapid diagnostic test for respiratory syncytial virus (RSV): potential for bedside diagnosis.

Authors:  L R Krilov; S M Lipson; S R Barone; M H Kaplan; Z Ciamician; S H Harkness
Journal:  Pediatrics       Date:  1994-06       Impact factor: 7.124

10.  Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons in a Belgian paediatric hospital.

Authors:  C Bonroy; A Vankeerberghen; A Boel; H De Beenhouwer
Journal:  Clin Microbiol Infect       Date:  2007-01-30       Impact factor: 8.067

View more
  55 in total

Review 1.  Respiratory Syncytial Virus Infection: An Illness for All Ages.

Authors:  Edward E Walsh
Journal:  Clin Chest Med       Date:  2016-12-27       Impact factor: 2.878

Review 2.  Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical UIse.

Authors:  Daniel Shyu; James Dorroh; Caleb Holtmeyer; Detlef Ritter; Anandhi Upendran; Raghuraman Kannan; Dima Dandachi; Christian Rojas-Moreno; Stevan P Whitt; Hariharan Regunath
Journal:  Mo Med       Date:  2020 May-Jun

Review 3.  Respiratory syncytial virüs infections in neonates and infants.

Authors:  Yıldız Perk; Mine Özdil
Journal:  Turk Pediatri Ars       Date:  2018-06-01

4.  Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses.

Authors:  Lifen Ling; Samuel E Kaplan; Juan C Lopez; Jeffrey Stiles; Xuedong Lu; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

Review 5.  Severe Respiratory Viral Infections: New Evidence and Changing Paradigms.

Authors:  James M Walter; Richard G Wunderink
Journal:  Infect Dis Clin North Am       Date:  2017-07-05       Impact factor: 5.982

6.  Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.

Authors:  Claire M Midgley; Amber K Haynes; Jason L Baumgardner; Christina Chommanard; Sara W Demas; Mila M Prill; Glen R Abedi; Aaron T Curns; John T Watson; Susan I Gerber
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

7.  The Use of Aerosolized Ribavirin in Respiratory Syncytial Virus Lower Respiratory Tract Infections in Adult Immunocompromised Patients: A Systematic Review.

Authors:  Lisa Avery; Charles Hoffmann; Karen M Whalen
Journal:  Hosp Pharm       Date:  2019-03-27

8.  Predictors of prolonged length of hospital stay for infants with bronchiolitis.

Authors:  Carlos E Rodríguez-Martínez; Monica P Sossa-Briceño; Gustavo Nino
Journal:  J Investig Med       Date:  2018-03-26       Impact factor: 2.895

Review 9.  Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests.

Authors:  Marwan M Azar; Marie L Landry
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

10.  Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children.

Authors:  Dithi Banerjee; Neena Kanwar; Ferdaus Hassan; Cynthia Essmyer; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.